Medical News

Risk of Incident Type 2 Diabetes in Patients with Psoriatic...
Int. J. Rheum. Dis.

Our study indicates a 38% increase in the risk of type 2 diabetes among patients with PsA, with an incidence rate...

30 Jun 2022

Higher Risk of Knee Arthroplasty During Ten-year Follow-up i...
BMC Musculoskelet. Disord.

In a sample of middle-aged individuals with complaints in one or both knees, the 10-year relative hazard for...

24 Jun 2022

Longitudinal Trajectories of Fatigue in Early RA: The Role o...
Annals of Rheumatol

Although fatigue evolves dynamically over time in early RA, most patients do not achieve sustained fatigue...

23 Jun 2022

2022 ACR/AAHKS Guideline for the Perioperative Management of...
J Arthroplasty

This updated guideline includes recently introduced immunosuppressive medications to help decision-making by...

20 Jun 2022

Key Trials

Efficacy of Teriparatide on Prior Use to Lumbar Fusion Surgery in Patients with Poor Bone Health

The present study assessed the two-year complication rates for patients who have poor bone health, with or without teriparatide pre-treatment before...

Risk MACE or Cancers with Tofacitinib verses TNF Inhibitor in RA Patients

This study assessed the risk of cardiovascular disease and cancer with tofacitinib and TNF inhibitor in patients with rheumatoid arthritis. The...

Effectiveness of ZOL as a First-line Therapeutic Strategy After Percutaneous Kyphoplasty

The present study evaluated the efficacy of zoledronic acid (ZOL) administration against previously treated recompression vertebral fractures (RVF)...

Cardioprotective Effect of Oral Bisphosphonates

The present study determined the risk of incident cardiovascular disease associated with oral BP (oBP) use in oBP users and non-users. The findings...

Patient Education

Osteoporosis:Video

The public awareness video gives an overview of osteoporosis and its management in patient friendly visuals and language.

General Awareness on Hydroxychloroquine Tablets

This educational input provides patient counselling information as per prescribing information on Hydroxychloroquine tablets regarding its therapeuti...

General Awareness on Methotrexate Tablets

This educational input provides patient counselling information as per prescribing information on methotrexate tablets regarding its therapeutic usag...

General Awareness on Tofacitinib Tablets

This educational input provides patient counselling information as per prescribing information on Tofacitinib tablets regarding its therapeutic usage...

Our Publications

Zotide (Teriparatide ) Monograph

The currently available pharmacological treatments for osteoporosis are predominantly anti-resorptive. These inhibit osteoclast-mediated bone loss...

Hyruan (Hyaluronic Acid) Monograph

Osteoarthritis (OA) is the most common form of arthritis and is a major cause of debilitation for affected individuals. One of the nonsurgical...

Calcinase (calcitonin) – Monograph

This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...

Imutrex (methotrexate) – Getting to the Heart of Rheumatoid Arthritis Abstracts Booklet

This publication features efficacy & safety studies of methotrexate in management of rheumatoid arthritis.

Slide Library

Intraarticular Hyaluronic acid for Osteoarthirits

The presentation includes description of synovial hyaluronic acid, its viscoelastic property, mechanism of action and different types available in...

 
Email this page
Osteoarthritis

This presentation shows the structure of bone joint majorly affected in osteoarthritis, its pathophysiology, risk factors, signs and symptoms and...

 
Email this page
Recommendations for Up & Downscaling of Methotrexate Dose in Rheumatoid Arthritis

Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...

 
Email this page
Musculoskeletal Manifestations of Ulcerative Colitis

This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...

 
Email this page

Poll

Which of the following bisphosphonate is preferred as first line treatment of osteoporosis-

Alendronate
71% (5 votes)
Risedronate
0% (0 votes)
Ibandronate
0% (0 votes)
Zoledronic acid
29% (2 votes)
Total votes: 7